Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

15.04.2021 | case report

Sphenoidal mucormycosis associated with large B-cell lymphoma: case report and literature review

verfasst von: Anis Chaari, MD, Esraa Turak, Mark Nashaat, Islam Aboayana, Vipin Kauts

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Summary

Mucormycosis is a rare but potentially life-threatening disease. Common risk factors include diabetic ketoacidosis, malignancies and bone marrow transplant. In patients with hematological malignancies mucormycosis often occurs in a context of neutropenia and/or following chemotherapy. We report a case of sphenoidal mucormycosis in a patient with large B‑cell lymphoma. This complication happened before any chemotherapy. The patient had normal neutrophils count and his diabetes was well controlled. Clinical course and management are discussed along with a review of the literature.
Vorheriger Artikel Cryptococcus neoformans meningitis in a patient with diffuse large B-cell lymphoma—a case report
Nächster Artikel Novel agents in a young patient with osteosarcoma: A short review
Literatur
1.
Itoh M, et al. Disseminated mucormycosis infection after the first course of dose-modified R‑EPOCH for advanced-stage lymphoma. Kansenshogaku Zasshi. 2014;88(6 Suppl 11):7–10.PubMed
2.
Roden MM, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53.CrossRef
3.
Tryfon S, et al. Rhinocerebral mucormycosis in a patient with latent diabetes mellitus: a case report. J Oral Maxillofac Surg. 2002;60(3):328–30.CrossRef
4.
Alacacioglu I, et al. Fatal disseminated mucormycosis in a patient with mantle cell non-Hodgkin’s lymphoma: an autopsy case. Braz J Infect Dis. 2009;13(3):238–41.CrossRef
5.
Cornely OA, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20(Suppl 3):5–26.CrossRef
6.
Bahloul M, et al. Rhinocerebral mucormycosis complicated by hemophagocytic lymphohistiocytosis: case report from Tunisia. Med Sante Trop. 2012;22(2):210–2.PubMed
7.
Chaari A, et al. Mucormycosis: an unusual cause of unilateral exophthalmia. J Mycol Med. 2013;23(2):140–3.CrossRef
8.
Hilal AA, Taj-Aldeen SJ, Mirghani AH. Rhinoorbital mucormycosis secondary to Rhizopus oryzae: a case report and literature review. Ear Nose Throat J. 2004;83(8):556–558–60, 562.CrossRef
9.
Valentine JC, et al. A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005–2016. BMC Infect Dis. 2019;19(1):274.CrossRef
10.
Chamilos G, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica. 2006;91(7):986–9.PubMed
11.
Nosari A, et al. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica. 2000;85(10):1068–71.PubMed
12.
Pagano L, et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell’Adulto). Br J Haematol. 1995;89(3):500–5.CrossRef
13.
Spellberg B, Edwards J Jr., Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556–69.CrossRef
14.
Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest. 1984;74(1):150–60.CrossRef
15.
Lewis RE, et al. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. 2013;56(6):638–45.CrossRef
16.
Pagano L, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto). Br J Haematol. 1997;99(2):331–6.CrossRef
17.
Lerchenmüller C, et al. Rhinocerebral zygomycosis in a patient with acute lymphoblastic leukemia. Ann Oncol. 2001;12(3):415–9.CrossRef
18.
Nithyanandam S, et al. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003;51(3):231–6.PubMed
19.
Mistro S, et al. Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis. Clin Infect Dis. 2012;54(12):1774–7.CrossRef
20.
Rodríguez MM, et al. Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrob Agents Chemother. 2009;53(12):5022–5.CrossRef
21.
Rodríguez MM, et al. Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice. Antimicrob Agents Chemother. 2010;54(5):1665–9.CrossRef
Metadaten
Titel
Sphenoidal mucormycosis associated with large B-cell lymphoma: case report and literature review
verfasst von
Anis Chaari, MD
Esraa Turak
Mark Nashaat
Islam Aboayana
Vipin Kauts
Publikationsdatum
15.04.2021
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2021
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-021-00705-5

Weitere Artikel der Ausgabe 3/2021

New trends in autologous and allogeneic stem cell transplantation—an update from the annual ASH meeting 2020

  • short review

SARS-CoV-2 vaccination in patients with solid tumors or hematological malignancies: Is the pandemic over for fully vaccinated patients?

  • editorial

A patient with liver cirrhosis and hepatic lesions

  • Open Access
  • case report

Pediatric oncology 2.0—shaping the future with precision

  • editorial

Decision making in hematology—chronic myeloid leukemia

  • Open Access
  • case report

Effect of the ABO blood groups on the development, clinical features and survival of multiple myeloma

  • original report